Manikay Partners’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,125,200
Closed -$32.2M 32
2018
Q4
$32.2M Buy
1,125,200
+700,200
+165% +$19.9M 3.13% 12
2018
Q3
$11.9M Buy
+425,000
New +$12M 0.83% 28

Other funds holding NXTM

Manikay Partners's NXTM Position: Q1 2019 in Review

Manikay Partners sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 1,125,200 shares — an estimated $32.2M sold.

Manikay Partners first reported a position in NXTM in Q3 2018 and held it in 2 quarters. The position peaked at $32.2M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Manikay Partners reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Manikay Partners sold 1,125,200 NxStage Medical Inc. shares in Q1 2019, an estimated $32.2M.
  • Manikay Partners first reported a position in NxStage Medical Inc. in Q3 2018 and held it in 2 quarters.
  • Manikay Partners's NxStage Medical Inc. position peaked at $32.2M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Manikay Partners's 13F filing for Q1 2019, filed 15 May 2019.